Dr. Foulds obtained a first class honors degree in psychology at the University of Aberdeen in Scotland before training as a Clinical Psychologist at the University of Glasgow. At that time his main research interests were on the psychophysiology and treatment of blood-injury phobia and fainting.
In 1989 he moved to the world-renowned tobacco research group at the Institute of Psychiatry in London and focused his research and clinical work on tobacco addiction. While there he published the first placebo-controlled trials of transdermal nicotine patches in the UK, and also studied the psychological effects of nicotine in smokers and non-smokers.
In 1994 he moved to St George's Hospital Medical School in London where he became the UK's first "Lecturer in Tobacco Addiction". While at St George's, Dr. Foulds was an investigator in the world's first randomized trial to directly compare nicotine patch, gum, inhaler and nasal spray, and also a large randomized trial of brief smoking cessation advice in pregnant women. He was also on the Management Group of the Hungarian Anti-Smoking Campaign (1995-6).
In 1997 he moved to the University of Surrey where he helped run a doctoral training course for Clinical Psychologists and was also a Principal Clinical Psychologist at Broadmoor Hospital, a large maximum security psychiatric hospital for mentally disordered offenders. However, he maintained a strong research interest in tobacco addiction, became technical leader of a World Health Organization project to improve the regulation of tobacco dependence treatment in Europe, and also became Director of Research for the charity, Quit, which ran the largest telephone helpline for smokers in the world at that time.
Dr. Foulds came to the School of Public Health at University of Medicine and Dentistry of New Jersey (UMDNJ) in the United States in 2000 to be the Director of the Tobacco Dependence Program. The program is funded by New Jersey Department of Health and Senior Services to train health professionals in New Jersey to treat tobacco dependence, and also runs its own Tobacco Dependence Clinic. In 2004 Dr. Foulds was elected to be Vice President of the Association for the Treatment of Tobacco use and Dependence. Dr. Foulds has therefore been conducting research on tobacco for over 16 years. While most of it has focused on treatment for addicted smokers, his work has also addressed such topics as the measurement of passive smoke exposure, the uptake of smoking in young people, the effects of nicotine on mental performance and the health effects of tobacco products. He has published over 70 articles in peer-reviewed journals.
Funding statement. This statement provides a brief summary of the sources of funding for Jonathan Foulds PhD.
Jonathan Foulds is primarily funded by a grant from New Jersey Department of Health and Senior Services. His other current research funding (also as P.I.) is from the Cancer Institute of New Jersey, and the Robert Wood Johnson Foundation. He has worked as a consultant, as a promotional speaker and received honoraria from pharmaceutical companies involved in production of tobacco dependence treatment medications, as well as a variety of agencies involved in promoting health (e.g. W.H.O., N.I.H., etc). A number of these agencies have provided sponsorship funds for educational events conducted by the program he directs. The program he directs (Tobacco Dependence Program at UMDNJ-School of Public Health) conducts trainings and charges health professionals and their organizations for providing these. He has also worked as an expert witness in litigation, including for plaintiffs in law suits against tobacco companies. He has not received any funding from the tobacco industry other than deposition fees from defendants attorneys in litigation against the tobacco industry (i.e. while acting as a witness for the plaintiffs). He is paid for writing a regular column on a health website: http://www.healthline.com/blogs/smoking_cessation/.